Rhodoled Xl
Payments companies reported to CMS as associated with Rhodoled Xl. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rhodoled Xl, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rhodoled Xl
These are the largest totals companies reported as associated with Rhodoled Xl. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Stockman | Saginaw, MI | Dermatopathology (Dermatology) | $21,456.19 |
| Ravindrakumar Gangadhariah | Davenport, IA | Dermatology | $15,792.00 |
| Armand Cognetta | Tallahassee, FL | Mohs-Micrographic Surgery | $14,909.48 |
| Joel Cohen | Greenwood Village, CO | Mohs-Micrographic Surgery | $13,718.35 |
| Ashish Bhatia | Itasca, IL | Procedural Dermatology | $13,715.96 |
| Brad Glick | Margate, FL | Dermatology | $13,583.26 |
| Peter Jenkin | Manchester, NH | Dermatology | $12,897.20 |
| David Goldberg | Hackensack, NJ | Mohs-Micrographic Surgery | $7,500.00 |
| Rawn Bosley | Grapevine, TX | Dermatology | $6,750.00 |
| Faraz Yousefian | San Antonio, TX | General Practice | $3,000.00 |
Prescribed Rhodoled Xl?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.